Contact Us

No Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

   * Please describe your case:

Date of Incident : 

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


European Drug Agency Backs Heart Warning

Feb 17, 2005 | AP

The European Medicines Agency said Thursday it would require stronger warnings about the cardiovascular risks associated with the Cox-2 class of arthritis painkillers.

It stopped short of calling for the drugs, which are also being scrutinized by the Food and Drug Administration, to be taken off the market.

After meeting this week in London, the agency's scientific experts said the Cox-2 medicines, used to alleviate the symptoms of rheumatoid arthritis, carry "an increased risk of cardiovascular adverse events."


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo